Head and Neck Carcinoma, Other — Trials

Head and Neck Carcinoma, Other — Trials · CancerIndex

Clinical trials

Registered studies

128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 35
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06814496	Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors(RABBIT)	recruiting	Phase 1 / Phase 2	30	University of ArizonaOTHER	1	Sep 22, 2026	clinicaltrials
NCT06176989	Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors	recruiting	Phase 2	40	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials